Eluxadoline (Viberzi and Truberzi) is a novel and potent μ- and κ-opioid receptor agonist and δ-opioid receptor antagonist that has been approved as an oral medication for the treatment of irritable bowel syndrome such as diarrhea and abdominal pain. It was approved in 2015 for clinical uses in the United States.

纯度：≥98%

CAS：864821-90-9